AT294815B - Verfahren zur Herstellung neuer 1-substituierter 3-Phenylpyrrolidine und ihrer Säureadditionssalze - Google Patents

Verfahren zur Herstellung neuer 1-substituierter 3-Phenylpyrrolidine und ihrer Säureadditionssalze

Info

Publication number
AT294815B
AT294815B AT325570A AT325570A AT294815B AT 294815 B AT294815 B AT 294815B AT 325570 A AT325570 A AT 325570A AT 325570 A AT325570 A AT 325570A AT 294815 B AT294815 B AT 294815B
Authority
AT
Austria
Prior art keywords
phenylpyrrolidines
substituted
preparation
new
acid addition
Prior art date
Application number
AT325570A
Other languages
English (en)
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Application granted granted Critical
Publication of AT294815B publication Critical patent/AT294815B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT325570A 1969-04-08 1970-04-09 Verfahren zur Herstellung neuer 1-substituierter 3-Phenylpyrrolidine und ihrer Säureadditionssalze AT294815B (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81444269A 1969-04-08 1969-04-08
US81444369A 1969-04-08 1969-04-08
US81549269A 1969-04-11 1969-04-11
US81549569A 1969-04-11 1969-04-11

Publications (1)

Publication Number Publication Date
AT294815B true AT294815B (de) 1971-12-10

Family

ID=27505843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT325570A AT294815B (de) 1969-04-08 1970-04-09 Verfahren zur Herstellung neuer 1-substituierter 3-Phenylpyrrolidine und ihrer Säureadditionssalze

Country Status (10)

Country Link
US (4) US3647790A (de)
AT (1) AT294815B (de)
BE (1) BE748392A (de)
CA (1) CA974995A (de)
CH (2) CH549038A (de)
DE (2) DE2017255A1 (de)
FR (2) FR2042322B1 (de)
GB (2) GB1299621A (de)
NL (1) NL7005191A (de)
SE (1) SE366040B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2541855A1 (de) * 1975-09-18 1977-03-31 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone ii
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
US4175129A (en) 1975-07-21 1979-11-20 Janssen Pharmaceutica N.V. Antiemetic 1-(benzoxazolylalkyl)-piperidine derivatives
US4035369A (en) * 1975-10-08 1977-07-12 Janssen Pharmaceutica N.V. 1-Benzazolylalkyl-4-substituted-piperidines
US4110333A (en) * 1976-05-17 1978-08-29 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
LU75478A1 (de) * 1976-07-28 1978-02-08
US4241061A (en) * 1979-05-21 1980-12-23 International Minerals & Chemical Corp. Oxazolidinyl-quinoxalines and use as growth promoters
US4303667A (en) * 1979-05-25 1981-12-01 Nippon Soda Company Limited Phenylprrole derivatives
US4426386A (en) * 1979-12-05 1984-01-17 Astra Lakemedel Aktiebolag Substituted phenyl piperidines
US4658028A (en) * 1980-08-07 1987-04-14 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4656276A (en) * 1980-08-07 1987-04-07 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4720548A (en) * 1980-08-07 1988-01-19 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4629790A (en) * 1980-08-07 1986-12-16 Angus Chemical Company Quinoxaline adducts useful as anthelmintics
US4348389A (en) * 1980-08-07 1982-09-07 International Minerals & Chemical Corp. Quinoxaline adducts useful as anthelmintics
US4661593A (en) * 1980-08-07 1987-04-28 Angus Chemcial Company Quinoxaline adducts useful as anthelmintics
DE3328643A1 (de) * 1983-08-09 1985-02-21 Gödecke AG, 1000 Berlin 3-aryl-3-pyrrolin-derivate, verfahren zu deren herstellung sowie deren verwendung bei der bekaempfung von herz- und gefaesskrankheiten
US5118816A (en) * 1990-12-26 1992-06-02 American Cyanamid Company 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds useful in the manufacture of insecticidal, nematocidal and acaricidal arylpyrroles
US5514678A (en) * 1992-03-26 1996-05-07 E. I. Du Pont De Nemours And Company Arthropodicidal 1,2,4-triazinyl amides
US5665754A (en) * 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
US6355659B1 (en) 1994-07-29 2002-03-12 Laboratorios Del Dr. Esteve, S.A. 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
WO1996004250A1 (en) * 1994-08-05 1996-02-15 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
US5883094A (en) * 1995-04-24 1999-03-16 Pfizer Inc. Benzimidazolone derivatives with central dopaminergic activity
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
GB9801392D0 (en) 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
ATE356804T1 (de) * 2002-06-14 2007-04-15 Merck & Co Inc Inhibitoren von mitotischem kinesin
CN100421665C (zh) * 2002-06-14 2008-10-01 麦克公司 有丝分裂驱动蛋白抑制剂
AU2003287057B2 (en) * 2002-10-18 2008-08-21 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
EP1664026B1 (de) * 2003-08-15 2009-01-21 Merck & Co., Inc. Inhibitoren von mitotischem kinesin
WO2005017190A2 (en) * 2003-08-15 2005-02-24 Merck & Co., Inc. Mitotic kinesin inhibitors
AU2004266629B2 (en) * 2003-08-15 2009-11-26 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
MX2007015617A (es) * 2005-06-10 2008-03-06 Elixir Pharmaceuticals Inc Compuestos de sulfonamida y usos de los mismos.
US7829589B2 (en) * 2005-06-10 2010-11-09 Elixir Pharmaceuticals, Inc. Sulfonamide compounds and uses thereof
FR2902790A1 (fr) * 2006-06-27 2007-12-28 Sanofi Aventis Sa Derives d'urees de piperidine ou pyrrolidine,leur preparation et leur application en therapeutique
EP2155671B8 (de) * 2007-06-05 2018-02-21 Integrative Research Laboratories Sweden AB Disubstituierte phenylpyrrolidine als modulatoren der kortikalen katecholaminergen neurotransmission
MX2009012716A (es) * 2007-06-05 2009-12-14 Nsab Af Neurosearch Sweden Ab Nuevas fenilpirrolidinas disustituidas como moduladores de la neurotransmision catecolaminergica cortical.
TWI457122B (zh) * 2007-07-20 2014-10-21 Orion Corp 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3－二氫苯並[1,4]戴奧辛－2－基甲基衍生物
UA104152C2 (ru) * 2008-11-24 2014-01-10 Интергрейтив Рисерч Лебореториз Сведен АБ Производные 3-фенил-3-метоксипирролидина, как модуляторы кортикальной катехоламинергической нейротрансмиссии
JOP20190050A1 (ar) 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز تخترق حاجز المخ الدموي
CN111479812A (zh) 2017-12-04 2020-07-31 巴尔-波特拉及康邦亚股份有限公司 多巴胺-b-羟化酶抑制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines

Also Published As

Publication number Publication date
US3635982A (en) 1972-01-18
US3644414A (en) 1972-02-22
US3647790A (en) 1972-03-07
BE748392A (fr) 1970-09-16
FR2042322A1 (de) 1971-02-12
FR2042321B1 (de) 1974-03-22
FR2042321A1 (de) 1971-02-12
CA974995A (en) 1975-09-23
GB1289089A (de) 1972-09-13
CH549038A (de) 1974-05-15
DE2017265A1 (de) 1970-10-15
FR2042322B1 (de) 1973-06-08
NL7005191A (de) 1970-10-13
US3634441A (en) 1972-01-11
SE366040B (de) 1974-04-08
DE2017255A1 (de) 1970-10-08
GB1299621A (en) 1972-12-13
CH556336A (de) 1974-11-29

Similar Documents

Publication Publication Date Title
AT294815B (de) Verfahren zur Herstellung neuer 1-substituierter 3-Phenylpyrrolidine und ihrer Säureadditionssalze
AT324327B (de) Verfahren zur herstellung neuer imidazolderivate und ihrer salze
AT300788B (de) Verfahren zur Herstellung neuer Imidazolderivate und ihrer Salze
AT294108B (de) Verfahren zur Herstellung neuer Benzamidoäthylpiperazine sowie ihrer Säureadditionssalze
AT295529B (de) Verfahren zur Herstellung neuer 5,6-Dimethoxy-indazol-3-carbonsäureamide und ihrer Salze
AT289108B (de) Verfahren zur Herstellung neuer Thiazolylbenzoesäurederivate und ihrer Salze
AT293367B (de) Verfahren zur Herstellung neuer basischer Phenoxyacetamide und ihrer Säureadditionssalze
AT309460B (de) Verfahren zur Herstellung neuer Phenacetylguanidine und ihrer Säureadditionssalze
AT308288B (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen und ihrer Säureadditionssalze
AT304556B (de) Verfahren zur Herstellung neuer Pyrimidin-Verbindungen und ihrer Säureadditionssalze
AT289126B (de) Verfahren zur Herstellung von neuen Imidazolidinonderivaten sowie ihrer Säureadditionssalze
AT298490B (de) Verfahren zur Herstellung von neuen 1,4-Dihydrochinolinderivaten und ihrer Säureadditionssalze
AT307387B (de) Verfahren zur Herstellung neuer substituierter 2-Amino-1-phenoxyäthane sowie ihrer Säureadditionssalze
AT301539B (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen und ihrer Säureadditionssalzen
AT295546B (de) Verfahren zur Herstellung neuer 1-substituierter-1H-1,2,8,9-Tetraazaphenalene und ihrer Säureadditionssalze
AT303029B (de) Verfahren zur Herstellung neuer 3,5-Dioxopyrazolidinderivate und ihrer Salze
AT307433B (de) Verfahren zur Herstellung neuer Pyrimidinderivate und ihrer Salze
AT302309B (de) Verfahren zur Herstellung von neuen Thiepinderivaten sowie ihrer Säureadditionssalzen
AT289812B (de) Verfahren zur Herstellung des neuen 2-Methyl-7-chlor-2,3,4,5-tetrahydro-1H-3-benzazepins sowie seiner Säureadditionssalze
AT306736B (de) Verfahren zur Herstellung von neuen Benzodiazepinderivaten sowie Säureadditionssalzen hievon
AT294827B (de) Verfahren zur Herstellung neuer 3-Sulfanilaminoisothiazole und ihrer Salze
AT307436B (de) Verfahren zur Herstellung neuer Pyrimidin-Derivate und ihrer Salze
AT309415B (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen und ihrer Säureadditionssalze
AT267498B (de) Verfahren zur Herstellung neuer N-Methyl-N-benzyl-propargylamine und ihrer Säureadditionssalze
AT316542B (de) Verfahren zur herstellung neuer indolderivate und ihrer saeureadditionssalze

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee